Lycurgus wrote:
Please stop offering critiques on the source of funding and start offering critiques on the design of the study if you believe that it is flawed. The source of the fuding itself does not do that. . . . Just because the results may serve the company doesn't automatically make them invalid. If you believe this then you probably have not spend any time in academic research.
Please stop offering strawmen to attack. Nobody has said that results that may serve the source of funding "automatically make them invalid." But a study that has been expressly and very publicly "commissioned" by a company to get a "Harvard researcher" to "assess the advantages" of the company's heavily marketed retail product is almost certainly going to be designed and interpreted in a way that favors the company. If you believe otherwise, then you probably haven't dealt very much with the use of experts to develop studies and reports for companies that pay the bills for those studies and reports. And that's a lot different from a study that's designed and interpreted to figure out how to design a better product, or to determine the efficacy and safety of various possible prescription drugs that have yet to be submitted for FDA approval, especially presciption drugs that are designed to effect easily meaurable changes (for example, drugs that are designed to lower blood cholesteral, as opposed to SSRI antidepressants). If you believe otherwise, then you're an idiot -- whether or not you've spent any time in academic research.
I was very interested in the study when I first heard about it on NPR Wesnesday afternoon (which happened to be almost precisely the same moment that Vibram put up an announcement of the publication of the study on its facebook page). I've been a rather extreme "minimalist" for many years, long before Vibram or any of these researchers got into the act, and I was looking forward to reading the study, hoping that it would provide some good and interesting support for the minimalist approach of companies like Vibram. But I lost almost all of my interest in the study when I discovered that it was funded by Vibram. Not because I dislike Vibram, and not because I dislike my alma mater. It's because I've routinely dealt with experts in many fields who are paid by vested interests to publish their findings, and I have found that I generally don't need to read their reports or listen to their testimony to know approximately what they're going to say and what their conclusions are going to be. I just need to know who is paying their bills.
I'm still waiting for the disclosure of the financial arrangement. (It would also be amusing to hear an explanation for the ways in which Vibram -- which, according to Vibram itself, was the funding source that commissioned the study -- was minimized as a funding source in the documentation for the study.)